These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9099602)

  • 1. Symposium on treatment of diabetic complications. 2. Diabetic neuropathy.
    Toyota T; Satoh J; Suzuki S
    Intern Med; 1997 Feb; 36(2):139-41. PubMed ID: 9099602
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
    Navarro JF; Milena FJ; Mora C; León C; Claverie F; Flores C; García J
    Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of oxidative stress in neuropathy and other diabetic complications.
    Van Dam PS; Van Asbeck BS; Erkelens DW; Marx JJ; Gispen WH; Bravenboer B
    Diabetes Metab Rev; 1995 Oct; 11(3):181-92. PubMed ID: 8536540
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenetic mechanisms of diabetic neuropathy: lessons from animal models.
    Yagihashi S
    J Peripher Nerv Syst; 1997; 2(2):113-32. PubMed ID: 10959225
    [No Abstract]   [Full Text] [Related]  

  • 5. Ameliorating human diabetic neuropathy: lessons from implanting hematopoietic mononuclear cells.
    Malik RA; Veves A; Tesfaye S
    Exp Neurol; 2006 Sep; 201(1):7-14. PubMed ID: 16808913
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in cardiac innervation during maturation in long-term diabetes.
    Bakovic M; Juric Paic M; Zdrilic E; Vukojevic K; Ferhatovic L; Marin A; Filipovic N; Grkovic I; Puljak L
    Exp Gerontol; 2013 Dec; 48(12):1473-8. PubMed ID: 24140619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regenerative processes in experimental diabetic neuropathy.
    Eliasson SG
    Trans Am Neurol Assoc; 1965; 90():35-7. PubMed ID: 5857772
    [No Abstract]   [Full Text] [Related]  

  • 8. Current aspects of research on the pathogenesis of diabetic neuropathy.
    Wuarin-Bierman L; Zahnd GR
    Diabete Metab; 1986 Dec; 12(6):319-24. PubMed ID: 3028879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide Promotes Morphine Efficacy and Prevents Morphine-Induced Tolerance in Rats with Diabetic Neuropathy.
    Zhao J; Wang H; Song T; Yang Y; Gu K; Ma P; Zhang Z; Shen L; Liu J; Wang W
    Neurochem Res; 2016 Dec; 41(12):3171-3180. PubMed ID: 27573481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal inhibition of calcium/calmodulin-dependent protein kinase II in diabetic neuropathy adversely affects pain-related behavior.
    Jelicic Kadic A; Boric M; Ferhatovic L; Banozic A; Sapunar D; Puljak L
    Neurosci Lett; 2013 Oct; 554():126-30. PubMed ID: 24035897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy.
    Obrosova IG; Fathallah L; Stevens MJ
    Exp Neurol; 2001 Nov; 172(1):211-9. PubMed ID: 11681853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific functioning of Cav3.2 T-type calcium and TRPV1 channels under different types of STZ-diabetic neuropathy.
    Khomula EV; Viatchenko-Karpinski VY; Borisyuk AL; Duzhyy DE; Belan PV; Voitenko NV
    Biochim Biophys Acta; 2013 May; 1832(5):636-49. PubMed ID: 23376589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient neurotrophic support in the aetiology of diabetic neuropathy.
    Tomlinson DR; Fernyhough P; Diemel LT; Maeda K
    Diabet Med; 1996 Jul; 13(7):679-81. PubMed ID: 8840106
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased vulnerability to demyelination in streptozotocin diabetic rats.
    Jaffey PB; Gelman BB
    J Comp Neurol; 1996 Sep; 373(1):55-61. PubMed ID: 8876462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effects of combination of tramadol and acetaminophen on painful diabetic neuropathy in streptozotocin-induced diabetic rats.
    Gong YH; Yu XR; Liu HL; Yang N; Zuo PP; Huang YG
    Acta Anaesthesiol Taiwan; 2011 Mar; 49(1):16-20. PubMed ID: 21453898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.
    Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM
    J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does neuropathy develop in animal models?
    Hounsom L; Tomlinson DR
    Clin Neurosci; 1997; 4(6):380-9. PubMed ID: 9358984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heterogeneity of diabetic neuropathy.
    Sima AA
    Front Biosci; 2008 May; 13():4809-16. PubMed ID: 18508546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic neuropathies.
    Sima AA; Thomas PK; Ishii D; Vinik A
    Diabetologia; 1997 Oct; 40 Suppl 3():B74-7. PubMed ID: 9345651
    [No Abstract]   [Full Text] [Related]  

  • 20. Ablation of a small subpopulation of diabetes-specific bone marrow-derived cells in mice protects against diabetic neuropathy.
    Urabe H; Terashima T; Kojima H; Chan L
    Am J Physiol Endocrinol Metab; 2016 Feb; 310(4):E269-75. PubMed ID: 26695138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.